Lane Michael 4

Accession 0000874716-24-000038

CIK 0000874716other

View on SEC.gov Company Profile

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 5:56 PM ET

Size

30.1 KB

Accession

0000874716-24-000038

Insider Transaction Report

Form 4

Period: 2024-02-14

IDEXX LABORATORIES INC /DEIDXX

Lane Michael

Executive Vice President

Transactions

Exercise/Conversion
Common Stock
2024-02-14+161→ 6,302.235 total
Award
Non-Qualified Stock Option (right-to-buy)
2024-02-14+5,407→ 5,407 total
Exercise: $560.56Exp: 2034-02-13→ Common Stock (5,407 underlying)
Award
Incentive Stock Option (right-to-buy)
2024-02-14+178→ 178 total
Exercise: $560.56Exp: 2034-02-13→ Common Stock (178 underlying)
Exercise/Conversion
Restricted Stock Unit
2024-02-14−161→ 160 total
→ Common Stock (161 underlying)
Exercise/Conversion
Common Stock
2024-02-14+204→ 6,506.235 total
Exercise/Conversion
Common Stock
2024-02-14+173→ 6,141.235 total
Tax Payment
Common Stock
2024-02-14$560.56/sh−283$158,638→ 6,443.235 total
Award
Restricted Stock Unit
2024-02-14+1,204→ 1,204 total
→ Common Stock (1,204 underlying)
Exercise/Conversion
Restricted Stock Unit
2024-02-14−173→ 0 total
→ Common Stock (173 underlying)
Exercise/Conversion
Common Stock
2024-02-14+220→ 6,726.235 total
Exercise/Conversion
Restricted Stock Unit
2024-02-14−204→ 408 total
→ Common Stock (204 underlying)
Exercise/Conversion
Restricted Stock Unit
2024-02-14−220→ 660 total
→ Common Stock (220 underlying)
Exercise/Conversion
Common Stock
2024-02-14+181→ 5,968.235 total
Exercise/Conversion
Restricted Stock Unit
2024-02-14−181→ 0 total
→ Common Stock (181 underlying)

Holdings

Common Stock
(indirect: By Spouse)
592

Footnotes (10)

[F1]Includes 13.2470 shares purchased under the Issuer Employee Stock Purchase Plan on December 29, 2023.
[F10]Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024.
[F2]Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
[F3]Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2025.
[F4]Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2028.
[F5]Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vest in four annual installments beginning on February 14, 2025.
[F6]Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2020.
[F7]Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning February 14, 2021.
[F8]Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
[F9]Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.

Documents

1 file

4
wk-form4_1708124172.xmlPrimary
FORM 4

Issuer

IDEXX LABORATORIES INC /DE

CIK 0000874716

→

Entity typeother

Related Parties

filerCIK 0001740689

Filing Metadata

Form type: 4
Filed: Feb 15, 7:00 PM ET
Accepted: Feb 16, 5:56 PM ET
Size: 30.1 KB

View on SEC.gov